Suppr超能文献

对 RSV 及其预防策略的意大利儿科医生样本的知识、态度和行为:一项横断面研究。

Knowledge, attitudes and behaviours of a sample of Italian paediatricians towards RSV and its preventive strategies: a cross-sectional study.

机构信息

Department of Life Science and Public Health, Section of Hygiene, Università Cattolica del Sacro Cuore, Roma, Italy.

Department Neurofarba, Università degli Studi di Firenze, Firenze, Italy.

出版信息

Ital J Pediatr. 2024 Feb 29;50(1):35. doi: 10.1186/s13052-024-01593-1.

Abstract

BACKGROUND

Respiratory Syncytial Virus (RSV) infection mainly affects newborns, infants and young children aged < 2 years. Since an RSV vaccine is in the European Medicines Agency's waitlist validation, nowadays the prevention only includes passive immunization with monoclonal antibodies (mAb). In the present study we aimed at investigating Italian paediatricians' knowledge, attitudes and behaviours towards RSV and its prevention.

METHODS

From February to May 2023, an anonymous online questionnaire, with answers based on the Likert scale, was administered to a sample of Italian paediatricians' members of the Italian Society of Paediatrics. Descriptive and inferential statistical analyses were performed using STATA 17.

RESULTS

The paediatricians who answered the questionnaire were 507, mostly women (70.6%), aged 30-45 (33.1%), employed in hospitals in 66.6% of cases. The 10.8% of respondents reported that RSV is transmitted only among children younger than 2 years of age and 80.33% of participants that school-age children are not at risk of developing severe forms of RSV disease. The 25% of participants thought that active immunization is currently available to prevent RSV infection and 35.7% that does not exist passive immunization to prevent RSV for infants and newborns aged < 2 years. The 97.5% of physicians managed bronchiolitis cases and 65.6% of participants did not prescribe the administration of mAb. Higher age, seniority and RSV knowledge score were found to be associated with having a higher mAb knowledge score (p < 0.001) and having a higher RSV knowledge was associated with a higher mAb knowledge score (p < 0.001). The logistic regression model found that the odds of a positive attitude towards mAB knowledge score increased by over 3 times (OR 3.23, 95% CI [1.41, 7.40], p = 0.006) for being female and the odds of a positive attitude towards mAB knowledge score increased by almost 10 times (OR 9.73, 95% CI [3.06, 30.89], p < 0.001) for a one-unit increase in RSV knowledge score.

CONCLUSIONS

Paediatricians' limited knowledge or awareness could represent a barrier to the implementation of preventive strategies against RSV infection. Strategies to improve paediatricians' education on RSV prevention are, therefore, crucial.

摘要

背景

呼吸道合胞病毒(RSV)感染主要影响新生儿、婴儿和 2 岁以下的幼儿。由于 RSV 疫苗在欧洲药品管理局的等待名单验证中,目前的预防措施仅包括使用单克隆抗体(mAb)进行被动免疫。在本研究中,我们旨在调查意大利儿科医生对 RSV 及其预防的知识、态度和行为。

方法

2023 年 2 月至 5 月,对意大利儿科学会成员的意大利儿科医生进行了一项匿名在线问卷调查,答案基于李克特量表。使用 STATA 17 进行描述性和推断性统计分析。

结果

回答问卷的儿科医生有 507 人,其中大多数是女性(70.6%),年龄在 30-45 岁之间(33.1%),66.6%的人在医院工作。10.8%的受访者报告说 RSV 仅在 2 岁以下的儿童中传播,80.33%的参与者认为学龄儿童不会有患严重 RSV 疾病的风险。25%的参与者认为目前有主动免疫可预防 RSV 感染,35.7%的人认为目前没有针对 2 岁以下婴儿和新生儿的 RSV 被动免疫。97.5%的医生管理毛细支气管炎病例,65.6%的参与者未开处方使用 mAb。较高的年龄、职称和 RSV 知识得分与更高的 mAb 知识得分相关(p<0.001),而较高的 RSV 知识得分与更高的 mAb 知识得分相关(p<0.001)。逻辑回归模型发现,对 mAb 知识评分持积极态度的几率增加了 3 倍以上(比值比 3.23,95%置信区间[1.41, 7.40],p=0.006),而对 mAb 知识评分持积极态度的几率增加了近 10 倍(比值比 9.73,95%置信区间[3.06, 30.89],p<0.001),因为 RSV 知识评分增加了 1 个单位。

结论

儿科医生知识或意识有限可能成为实施 RSV 感染预防策略的障碍。因此,提高儿科医生对 RSV 预防教育的策略至关重要。

相似文献

2
Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies.
Expert Rev Vaccines. 2022 Oct;21(10):1523-1531. doi: 10.1080/14760584.2022.2108799. Epub 2022 Sep 5.
4
Passive and active immunization against respiratory syncytial virus for the young and old.
Expert Rev Vaccines. 2017 Jul;16(7):1-13. doi: 10.1080/14760584.2017.1333425. Epub 2017 Jun 7.
7
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
Front Immunol. 2022 Apr 28;13:880368. doi: 10.3389/fimmu.2022.880368. eCollection 2022.

引用本文的文献

3
Knowledge, attitude, and perception regarding the respiratory syncytial virus vaccine among healthcare professionals.
J Pharm Policy Pract. 2025 Mar 28;18(1):2482669. doi: 10.1080/20523211.2025.2482669. eCollection 2025.
4
Knowledge and Attitudes Regarding Respiratory Syncytial Virus (RSV) Prevention: A Systematic Review.
Vaccines (Basel). 2025 Feb 6;13(2):159. doi: 10.3390/vaccines13020159.
5
Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2365804. doi: 10.1080/21645515.2024.2365804. Epub 2024 Jun 18.

本文引用的文献

4
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
N Engl J Med. 2022 Mar 3;386(9):892-894. doi: 10.1056/NEJMc2112186.
5
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.
N Engl J Med. 2022 Mar 3;386(9):837-846. doi: 10.1056/NEJMoa2110275.
6
Outbreak of Respiratory Syncytial Virus Bronchiolitis in Italy.
Clin Infect Dis. 2022 Aug 31;75(3):549-550. doi: 10.1093/cid/ciac120.
7
RSV: perspectives to strengthen the need for protection in all infants.
Emerg Themes Epidemiol. 2021 Oct 21;18(1):15. doi: 10.1186/s12982-021-00104-5.
8
Epidemiology and prevention of respiratory syncytial virus infections in children in Italy.
Ital J Pediatr. 2021 Oct 2;47(1):198. doi: 10.1186/s13052-021-01148-8.
9
Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries.
Influenza Other Respir Viruses. 2021 Nov;15(6):732-741. doi: 10.1111/irv.12885. Epub 2021 Jul 13.
10
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.
N Engl J Med. 2020 Jul 30;383(5):415-425. doi: 10.1056/NEJMoa1913556.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验